Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 3/20 | 0.45 |
| ▸ | CNR1 | P21554 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TOP2A | P11388 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | BCL9 | O00512 | 1/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7827434 | 0.84 | PLA2G4B (0.53) | ESR1 | |
| SCHEMBL2538773 | 0.82 | GAA (0.58) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 | |
| SCHEMBL31312898 | 0.81 | GAA (0.60) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 | |
| SCHEMBL3663773 | 0.81 | GAA (0.60) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 | |
| SCHEMBL4304737 | 0.81 | GAA (0.60) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 | |
| SCHEMBL1918538 | 0.81 | GAA (0.60) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 | |
| SCHEMBL991982 | 0.81 | GAA (0.60) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 | |
| SCHEMBL2535107 | 0.81 | GAA (0.60) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 | |
| SCHEMBL11622337 | 0.81 | GAA (0.60) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 | |
| SCHEMBL475206 | 0.81 | GAA (0.60) | KMT2ASMN1; SMN2ALOX15ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7638590-B2 | Polyhydroxyalkanoate having amide, sulfonic acid or sulfonate ester group, charge control agent and toner | CANON KABUSHIKI KAISHA (JP) | 2009-12-29 | — | — | US | disclosed |
| US-7527809-B2 | Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| US-7393912-B2 | Polyhydroxyalkanoate containing amide group, sulfonic group, and sulfonate ester group, method for producing the same, and charge control agent, toner, image forming method, and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2008-07-01 | — | — | US | disclosed |
| US-20060287473-A1 | Novel polyhydroxyalkanoate having amide, sulfonic acid or sulfonate ester group, charge control agent and toner | CANON KABUSHIKI KAISHA (JP) | 2006-12-21 | — | — | US | disclosed |
| US-20060263432-A1 | Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response | CANON KABUSHIKI KAISHA (JP) | 2006-11-23 | — | — | US | disclosed |
| EP-1579277-B1 | POLYHYDROXYALKANOATE CONTAINING AMIDE GROUP, SULFONIC GROUP, AND SULFONATE ESTER GROUP, METHOD FOR PRODUCING THE SAME, AND CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KK (JP) | 2006-09-06 | — | — | EP | disclosed |
| EP-1579276-B1 | NOVEL POLYHYDROXYALKANOATE HAVING AMIDE, SULFONIC ACID OR SULFONATE ESTER GROUP, CHARGE CONTROL AGENT AND TONER | CANON KK (JP) | 2006-08-09 | — | — | EP | disclosed |
| US-20060014921-A1 | Polyhydroxyalkanoate containing amide group, sulfonic group, and sulfonate ester group, method for producing the same, and charge control agent, toner, image forming method, and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2006-01-19 | — | — | US | disclosed |
| EP-1579276-A1 | NOVEL POLYHYDROXYALKANOATE HAVING AMIDE, SULFONIC ACID OR SULFONATE ESTER GROUP, CHARGE CONTROL AGENT AND TONER | CANON KABUSHIKI KAISHA (JP) | 2005-09-28 | — | — | EP | disclosed |
| EP-1579277-A1 | POLYHYDROXYALKANOATE CONTAINING AMIDE GROUP, SULFONIC GROUP, AND SULFONATE ESTER GROUP, METHOD FOR PRODUCING THE SAME, AND CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | Canon Kabushiki Kaisha (JP) | 2005-09-28 | — | — | EP | disclosed |
| US-6861496-B2 | Polyhydroxyalkonoate and method of producing same, and ω-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2005-03-01 | — | — | US | disclosed |
| WO-2004096188-A1 | POLYHYDROXYALKANOATE-CONTAINING MAGNETIC STRUCTURE, AND MANUFACTURING METHOD AND USE THEREOF | CANON KABUSHIKI KAISHA (JP) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004061530-A1 | POLYHYDROXYALKANOATE CONTAINING AMIDE GROUP, SULFONIC GROUP, AND SULFONATE ESTER GROUP, METHOD FOR PRODUCING THE SAME, AND CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2004-07-22 | — | — | WO | disclosed |
| WO-2004061529-A1 | NOVEL POLYHYDROXYALKANOATE HAVING AMIDE, SULFONIC ACID OR SULFONATE ESTER GROUP, CHARGE CONTROL AGENT AND TONER | CANON KABUSHIKI KAISHA (JP) | 2004-07-22 | — | — | WO | disclosed |
| US-20040062811-A1 | Polyhydroxyalkonoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA | 2004-04-01 | — | — | US | disclosed |
| US-6686439-B2 | POLYHYDROXYALKANOATE FOR USE IN CULTURING MICROORGANISMS | CANON KABUSHIKI KAISHA (JP) | 2004-02-03 | — | — | US | disclosed |
| US-20020164726-A1 | Polyhydroxyalkanoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2002-11-07 | — | — | US | disclosed |
| EP-1236754-A2 | Polyhydroxyalkanoate and method of producing same, and omega-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2002-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040062811-A1 | Polyhydroxyalkonoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same | HACL2, PAH, TST | KMT2A 1966/4885SMN1; SMN2 4866/4885ALOX15 182/4885 |
| US-20060263432-A1 | Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response | SKP1, HAMP, AUP1 | KMT2A 3735/4885SMN1; SMN2 3508/4885ALOX15 439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.